The Garlock family of companies will showcase high-fluid sealing and pipeline protection products at 'Korea Pharm 2017' which is held in KINTEX from April 18th to 21st.
The Garlock family of companies is acknowledged as the global leader in high-fluid sealing and pipeline protection products for industry and infrastructure. Garlock products are at work in many specialty industries, including chemical and petrochemical, refining, pulp and paper, water and wastewater treatment and drainage, power generation, primary metals, food and pharmaceuticals, infrastructure, mining and others.
Today, Garlock have 18 global operations employing more than 2,000 people and a distributor network that covers 75 countries. 13 manufacturing facilities in the U.S., Canada, Europe, Asia and Latin America collectively produce the broadest range of products for industrial fluid sealing and the maintenance of pipeline integrity. In addition, Garlock operate the most extensive testing facilities in the industry.
In April 2016, Garlock acquired the assets of Rubber Fab Gasket & Molding, Inc, a privately-held company offering a full range of high performance sanitary gaskets, hoses and fittings for the hygienic process industries. Being a recognized supplier of critical process consumables for pharmaceutical, bio-processing and food & beverage sectors with revenues of approximately $17 million, the addition of Rubber Fab expands Garlock's existing sealing solutions to provide a truly comprehensive portfolio.
Moving forward, Garlock will continue to develop the next-generation technologies that are changing the way industrial and infrastructure users meet their sealing requirements. By combining the most innovative products with unparalleled service and a strong environmental commitment, we deliver solutions that improve plant productivity, reduce costs and comply with increasingly stringent environmental regulations. Continued investment in research and development, new product innovations, production facilities, customer support and environmental initiatives are assurances that we will retain our global leadership in sealing technologies.
Meanwhile, KOREA PHARM propels globalization and promotion of domestic medicine and supports them to enter in global markets. It is hosted by Korea Pharmaceutical Manufacturers Association and Kyungyon Exhibition Corp. and supported by Ministry of Food and Drug Safety. MFDS Pharmaceutical Policy Seminar, Pharmaceutical Plant Manager Discussion Meeting, Bio Pharmaceutical Forum and Symposium and Seminar on Pharmaceutical Industry are also run at the same time.
→ Go to 'KOREA PHARM' News